CBA 2010 Annual Conference A Sea Change: Advancement in Biotech and Pharmaceutical Industry

12:00-1:00 Registration

1:00–1:10 Welcome Remarks

1:10–3:15 Plenary Session Opportunities and Challenges in the Development of Novel Small Molecule Therapeutics for

Oncology Dr. Peter Lamb, CSO and Executive VP Discovery, Exelixis

Obstacles to the Commercialization of the First Inhaled Insulin Product, Exubera Dr. John Patton, Founder and CEO, Dance Pharmaceuticals

Title (TBD) Dr. Kevin Moore, Executive Director, Amgen

Kaletra: a Second Generation Protease Inhibitor From Abbott Laboratories Dr. Hing Sham, Senior VP, Chemical Sciences, Elan Pharmaceuticals

Landscape and Industry Outlook of In Vitro Diagnostics Dr. Jimmy Zhang, Senior VP, Synergenics

3:15–3:40 Coffee Break

3:40–5:45 Advances in Diagnostics and Biomarkers New Waves in Therapeutic Drug Development

Translating Gene Expression Patterns into Commercialized Cancer Diagnostics Dr. Douglas Ross, CSO, Clarient Inc.

4

Strategies for Developing Pharmacodynamic and Predictive Biomarkers to Target Cancer Stem Cell Agents Dr. Ann Kapoun, Senior Director Translational Medicine, OncoMed Pharmaceuticals

RNAscope™, a Novel RNA In Situ Hybridization Platform for Personalized Medicine Dr. Yuling Luo, Founder, President and CEO, Advanced Cell Diagnostics Inc.

Introducing a Novel, Semiconductor Chip-Based Platform for DNA Biomarker Discovery and Personalized Medicine Dr. Gary Zweiger, VP, Business Development, BioNanomatrix Inc Panel Discussion

Capturing the Value of a Drug Before It Hits the Market

New Strategies in Drug Development from an Investor's Point of View Dr. Jim Larrick, TENEX Medical Investors & 7X Investment Fund

Changing Business Model for Changing Times: the Rise of Virtual Innovation

Dr. Yiyou Chen, CSO & Co-founder, Crown Biosciences

Generation of Customized Medicines through Molecular Profiling

Conducting Personalized Medicine with the Assistance of Biostatisticians. Dr. Xiaowei Yang, CEO, BayesSoft

Next Generation Biology through next Generation DNA Sequencing Dr. Dawei Lin, Director Bioinformatics Core, UC Davis

Data-Driven Drug Discovery and Personalized Medicine Mr. Joel Dudley, Bioinformatics Specialist, Butte Lab

6:00–6:45 Networking Mixer and Exhibits

6:45–9:00 Dinner, Keynote and Live Entertainment

Keynote Seminar: ‘The Great Recession’: How US consumer is reacting to it and the implications for international trade

Professor David Robinson, Haas Business School, UC Berkeley & Santa Clara University